33 results
Who to test for BRCA 1/2?
Female Breast Cancer:
 • ≤ 45-50 years at diagnosis
 • Triple
45-50 years at diagnosis ... cancer and: Ashkenazi ... BRCA #testing #indications ... #oncology #Breast ... #diagnosis
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
For most indications ... #management #algorithm ... #pharmacology #treatment ... #medications #table ... decisionaid #cardiology #hematology
Initial triage of the neutropenic adult - Algorithm for the evaluation and treatment of adult patients
the evaluation and ... treatment of adult ... Algorithm #workup #diagnosis ... #hematology #biopsy ... #indications #differential
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
incidental DVT or PE in cancer ... thrombosis in cancer ... †The decision to ... Anticoagulation #Management ... #Hematology #Oncology
Causes of Leukocytosis and Leukopenia - Differential Diagnosis
 • Eosinophilia (AEC > 500, hypereosinophilia > 1500):
of Leukocytosis and ... Infections, Autoimmune, Medications ... , Cancer, Nutritional ... Reactive (Infection, medications ... #causes #hematology
Overview of Biologics used for psoriasis

Information gathered from various phase 2 and phase 3 studies of
various phase 2 and ... phase 3 studies of medications ... #clinical #management ... #dermatology #psoriasis ... #treatment
Approach to Thrombocytosis - Elevated Platelet Count - Differential Diagnosis Algorithm

Peripheral Smear concerning for malignancy?
→ Refer to hematology ... Rebound effect from treatment ... Malignancy: Metastatic cancer ... • Reaction to Medications ... #Algorithm #hematology
Myelodysplastic Syndrome (MD) - Diagnosis and Management Summary
myelo (marrow) -dys- (abnormal) -plastic (shape) = funny-shaped cells
and Management ... acute leukemia Management ... only curative treatment ... #Management #treatment ... #hematology #oncology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
algorithm for the treatment ... of cancer-associated ... Currently, edoxaban and ... Anticoagulation #Management ... #Hematology #Oncology
Hematuria in Post-Renal Transplant Patient
Prevalence up to 12% in the postrenal transplant patient
 • Bacterial: Escherichia
., Prostate cancer ... • Medications ... #differential #diagnosis ... #blood #urine #management ... #treatment #nephrology